MedPath

A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures

Completed
Conditions
Subjects Who Have Undergone Benign Non-tumor TORS Procedures Using the da Vinci Surgical System
Interventions
Device: robotic surgery using the da Vinci Surgical System
Registration Number
NCT02002845
Lead Sponsor
Intuitive Surgical
Brief Summary

A retrospective multicenter investigation of the use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures. The study objectives are to evaluate the safety and effectiveness of the da Vinci Surgical System in subjects undergoing Benign Non-tumor procedures.

Detailed Description

Primary Effectiveness Endpoint:

• Ability to complete procedure without a need for conversion to a non-robotic approach

Safety Endpoint:

Assessment of adverse events through post-operative follow-up including but not limited to:

• Bleeding

▪ Mortality

Additional endpoints evaluated may include:

* Procedure times

* Length of hospital stay

* Volume of tissue resected

* Use of tissue sealants

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
285
Inclusion Criteria
  • The specific surgical procedure involved a lingual tonsillectomy, tongue base resection, or a partial glossectomy procedure.
  • Subject was ≥18 years of age at the time of procedure
Read More
Exclusion Criteria
  • Subject underwent a benign non-tumor TORS procedure that did not involve either a lingual tonsillectomy, tongue base resection or partial glossectomy.
  • Subject underwent a TORS procedure for oropharyngeal cancer
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Robotic armrobotic surgery using the da Vinci Surgical SystemPatient who have undergone benign non-tumor TORS procedures using the da Vinci Surgical System
Primary Outcome Measures
NameTimeMethod
Primary Effectiveness Endpointintra-operative

Ability to complete procedure without a need for conversion to a non-robotic approach

Primary Safety endpointup to 30 days after surgery

Assessment of adverse events through post-operative follow-up including but not limited to:

• Bleeding

▪ Mortality

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Middlesex Hospital

🇺🇸

Middletown, Connecticut, United States

St. Jose Mercey Health System

🇺🇸

Ypsilanti, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath